495 related articles for article (PubMed ID: 11659324)
1. Women and HIV/AIDS research: the barriers to equity.
Levine C
IRB; 1991; 13(1-2):18-22. PubMed ID: 11659324
[No Abstract] [Full Text] [Related]
2. Protectionism and the new research imperative in pediatric AIDS.
Ackerman TF
IRB; 1990; 12(5):1-5. PubMed ID: 11654001
[No Abstract] [Full Text] [Related]
3. Informed consent: the FDA's perspective.
Bagley G
Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
[No Abstract] [Full Text] [Related]
4. Off the pedestal and into the arena: toward including women in experimental protocols.
Gorenberg H; White A
Rev Law Soc Change; 1991-1992; 19(1):205-46. PubMed ID: 11659599
[No Abstract] [Full Text] [Related]
5. Women in clinical trials: concluding remarks.
Buc NL
Food Drug Law J; 1993; 48(2):223-6. PubMed ID: 11653146
[No Abstract] [Full Text] [Related]
6. Exclusion of pregnant women from research protocols: unethical and illegal.
Hall JK
IRB; 1995; 17(2):1-3. PubMed ID: 11653053
[No Abstract] [Full Text] [Related]
7. Women's and fetal rights and interests: ethical aspects.
Fletcher JC
Food Drug Law J; 1993; 48(2):213-21. PubMed ID: 11653145
[No Abstract] [Full Text] [Related]
8. The invisible woman: gender bias in medical research.
Keville TD
Womens Rights Law Report; 1994; 15():123-42. PubMed ID: 11660409
[No Abstract] [Full Text] [Related]
9. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
10. The paradoxical case of payment as benefit to research subjects.
Macklin R
IRB; 1989; 11(6):1-3. PubMed ID: 11650284
[No Abstract] [Full Text] [Related]
11. Abortion politics, science, and research ethics: take down the wall of separation.
Fletcher JC
J Contemp Health Law Policy; 1992; 8():95-121. PubMed ID: 11645741
[No Abstract] [Full Text] [Related]
12. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
13. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
14. Regulatory concerns regarding AIDS vaccine development.
Sawyer LA; Katzenstein DA; Quinnan GV
AIDS Public Policy J; 1988; 3(3):36-45. PubMed ID: 11650100
[No Abstract] [Full Text] [Related]
15. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
16. There is no women's health crisis.
Satel SL
Public Interest; 1998; 130():21-33. PubMed ID: 11658109
[No Abstract] [Full Text] [Related]
17. Protecting us to death: women, pregnancy, and clinical research trials.
Charo RA
St Louis Univ Law J; 1993; 38(1):135-87. PubMed ID: 11656322
[No Abstract] [Full Text] [Related]
18. AIDS treatment drugs: clinical trials and compassionate use.
Levine RJ
AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
[No Abstract] [Full Text] [Related]
19. Twice wrong on AIDS.
Gieringer D
N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161
[No Abstract] [Full Text] [Related]
20. AIDS and drug pricing: in search of a policy.
Salbu SR
Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
